Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01164 (Long intergenic non-protein coding RNA 1164) is a human long intergenic non-coding RNA from chromosome 7, likely involved in transcriptional regulation as part of the broader lincRNA family, which frequently participate in modulation of gene expression[5]. Unlike some other lincRNAs whose disease roles and cellular functions are characterized, the specific biological functions, disease associations, or relevance of LINC01164 remain uncharacterized in published experimental literature. There is no evidence of receptor function, enzymatic activity, or known therapeutic targeting[5].\n\nIf you require information about a similarly named molecule (e.g., LINC01116 or LINC01184), those are well-studied lincRNAs with established roles in cancer biology and cellular processes[1][2]. However, current evidence does not support direct disease association or therapeutic target status for LINC01164.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1164 (LINC01164).